Caption Management’s Agios Pharmaceuticals AGIO Stock Holding History

Caption Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-107,300	Closed	-$2.92M	–	1504
2025 Q4	$2.92M	Sell	107,300 -279,300	-72%	-$9.8M	0.02%	697
2025 Q3	$15.5M	Buy	386,600 +224,200	+138%	+$8.43M	0.12%	182
2025 Q2	$5.4M	Buy	162,400 +46,400	+40%	+$1.41M	0.06%	385
2025 Q1	$3.4M	Sell	116,000 -31,500	-21%	-$1.04M	0.03%	513
2024 Q4	$4.85M	Sell	147,500 -152,500	-51%	-$7.16M	0.05%	383
2024 Q3	$13.3M	Buy	300,000 +272,500	+991%	+$12.4M	0.21%	115
2024 Q2	$1.19M	Sell	27,500 -100,000	-78%	-$3.61M	0.02%	623
2024 Q1	$3.73M	Buy	+127,500	New	+$3.41M	0.06%	366
2023 Q4	–	Sell	-60,000	Closed	-$1.49M	–	1307
2023 Q3	$1.49M	Hold	60,000	–	–	0.02%	659
2023 Q2	$1.7M	Buy	60,000 +30,000	+100%	+$747K	0.03%	539
2023 Q1	$689K	Hold	30,000	–	–	0.01%	718
2022 Q4	$842K	Sell	30,000 -85,000	-74%	-$2.4M	0.01%	804
2022 Q3	$3.25M	Buy	+115,000	New	+$3.08M	0.04%	488
2022 Q2	–	Sell	-57,500	Closed	-$1.68M	–	1401
2022 Q1	$1.68M	Sell	57,500 -5,000	-8%	-$153K	0.02%	814
2021 Q4	$2.06M	Buy	+62,500	New	+$2.52M	0.02%	783
2021 Q3	–	Sell	-50,000	Closed	-$2.76M	–	1469
2021 Q2	$2.76M	Buy	+50,000	New	+$2.8M	0.04%	565
2021 Q1	–	Sell	-25,000	Closed	-$1.08M	–	1006
2020 Q4	$1.08M	Sell	25,000 -25,000	-50%	-$988K	0.02%	592
2020 Q3	$1.75M	Sell	50,000 -10,000	-17%	-$438K	0.04%	475
2020 Q2	$3.21M	Buy	60,000 +46,500	+344%	+$2.15M	0.11%	261
2020 Q1	$478K	Sell	13,500 -1,500	-10%	-$69.3K	0.03%	555
2019 Q4	$716K	Sell	15,000 -186,000	-93%	-$7.03M	0.02%	566
2019 Q3	$6.51M	Buy	+201,000	New	+$8.32M	0.34%	77

Other funds holding AGIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Caption Management's AGIO Position: Q1 2026 in Review

Caption Management reduced its Agios Pharmaceuticals (AGIO) stake by 87% in Q1 2026, selling an estimated $2.3M and leaving 12,349 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #1244.

Caption Management first reported a position in AGIO in Q3 2019 and has held it in 18 quarters since. The position peaked at $4.03M in Q1 2021. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

Caption Management held 12,349 shares of Agios Pharmaceuticals worth $418K as of Q1 2026.
Caption Management sold 81,137 Agios Pharmaceuticals shares in Q1 2026, an estimated $2.3M.
Agios Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1244 holding.
Caption Management first reported a position in Agios Pharmaceuticals in Q3 2019 and has held it in 18 quarters since.
Caption Management's Agios Pharmaceuticals position peaked at $4.03M in Q1 2021.
232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.